176 related articles for article (PubMed ID: 27518899)
1. Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves.
Zahin M; Joh J; Khanal S; Husk A; Mason H; Warzecha H; Ghim SJ; Miller DM; Matoba N; Jenson AB
PLoS One; 2016; 11(8):e0160995. PubMed ID: 27518899
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
Pineo CB; Hitzeroth II; Rybicki EP
Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054
[TBL] [Abstract][Full Text] [Related]
3. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
[TBL] [Abstract][Full Text] [Related]
4. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
[TBL] [Abstract][Full Text] [Related]
5. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
6. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
[TBL] [Abstract][Full Text] [Related]
7. High-Level Production of Human Papillomavirus (HPV) Type 16 L1 in Escherichia coli.
Bang HB; Lee YH; Lee YJ; Jeong KJ
J Microbiol Biotechnol; 2016 Feb; 26(2):356-63. PubMed ID: 26608168
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods.
Matić S; Masenga V; Poli A; Rinaldi R; Milne RG; Vecchiati M; Noris E
Plant Biotechnol J; 2012 May; 10(4):410-21. PubMed ID: 22260326
[TBL] [Abstract][Full Text] [Related]
9. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.
Waheed MT; Thönes N; Müller M; Hassan SW; Razavi NM; Lössl E; Kaul HP; Lössl AG
Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembling Plant-Derived Vaccines Against Papillomaviruses.
Noris E
Methods Mol Biol; 2018; 1776():85-95. PubMed ID: 29869236
[TBL] [Abstract][Full Text] [Related]
11. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
12. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
Matić S; Rinaldi R; Masenga V; Noris E
BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.
Fernández-San Millán A; Ortigosa SM; Hervás-Stubbs S; Corral-Martínez P; Seguí-Simarro JM; Gaétan J; Coursaget P; Veramendi J
Plant Biotechnol J; 2008 Jun; 6(5):427-41. PubMed ID: 18422886
[TBL] [Abstract][Full Text] [Related]
14. Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.
Lenzi P; Scotti N; Alagna F; Tornesello ML; Pompa A; Vitale A; De Stradis A; Monti L; Grillo S; Buonaguro FM; Maliga P; Cardi T
Transgenic Res; 2008 Dec; 17(6):1091-102. PubMed ID: 18491213
[TBL] [Abstract][Full Text] [Related]
15. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
16. Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector.
Varsani A; Williamson AL; Stewart D; Rybicki EP
Virus Res; 2006 Sep; 120(1-2):91-6. PubMed ID: 16530873
[TBL] [Abstract][Full Text] [Related]
17. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
18. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
Kim SN; Jeong HS; Park SN; Kim HJ
J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
[TBL] [Abstract][Full Text] [Related]
19. Assembly of Human Papillomavirus 16 L1 Protein in
Muthamilselvan T; Khan MRI; Hwang I
J Plant Biol; 2023 Apr; ():1-10. PubMed ID: 37360984
[TBL] [Abstract][Full Text] [Related]
20. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
